Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells

被引:934
作者
Lund, J
Sato, A
Akira, S
Medzhitov, R
Iwasaki, A
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[3] Osaka Univ, SORST, Japan Sci & Technol Corp, Microbial Dis Res Inst,Dept Host Def, Suita, Osaka 5650871, Japan
关键词
type I interferons; CpG motif; innate immunity; virus infection; DNA virus;
D O I
10.1084/jem.20030162
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (pDCs) have been identified as a potent secretor of the type I interferons (IFNs) in response to CpG as well as several viruses. In this study, we examined the molecular mechanism of virus recognition by pDCs. First, we demonstrated that the CD11c(+)Gr-1(int)B220(+) pDCs from mouse bone marrow secreted high levels of IFN-alpha in response to either live or UV-inactivated Herpes simplex virus-2 (HSV-2). Next, we identified that IFN-alpha secretion by pDCs required the expression of the adaptor molecule MyD88, suggesting the involvement of a Toll-like receptor (TLR) in HSV-2 recognition. To test whether a TLR, mediates HSV-2-induced IFN-alpha. secretion from pDCs, various knockout mice were examined. These experiments revealed a clear requirement for TLR9 in this process. Further, we demonstrated that purified HSV-2 DNA can trigger IFN-alpha secretion from pDCs and that inhibitory CpG oligonucleotide treatment diminished HSV-induced IFN-alpha secretion by pDCs in a dose-dependent manner. The recognition of HSV-2 by TLR9 was mediated through an endocytic pathway that was inhibited by chloroquine or bafilomycin A1. The strict requirement for TLR9 in IFN-alpha secretion was further confirmed by the inoculation of HSV-2 in vivo. Therefore, these results demonstrate a novel mechanism whereby the genomic DNA of a virus can engage TLR9 and result in the secretion of IFN-alpha by pDCs.
引用
收藏
页码:513 / 520
页数:8
相关论文
共 34 条
  • [21] WHY IS CPG SUPPRESSED IN THE GENOMES OF VIRTUALLY ALL SMALL EUKARYOTIC VIRUSES BUT NOT IN THOSE OF LARGE EUKARYOTIC VIRUSES
    KARLIN, S
    DOERFLER, W
    CARDON, LR
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 2889 - 2897
  • [22] Viruses and interferon: A fight for supremacy
    Katze, MG
    He, YP
    Gale, M
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) : 675 - 687
  • [23] Toll-like receptors and innate immunity
    Medzhitov, R
    [J]. NATURE REVIEWS IMMUNOLOGY, 2001, 1 (02) : 135 - 145
  • [24] FUNCTIONAL-ROLE OF TYPE-I AND TYPE-II INTERFERONS IN ANTIVIRAL DEFENSE
    MULLER, U
    STEINHOFF, U
    REIS, LFL
    HEMMI, S
    PAVLOVIC, J
    ZINKERNAGEL, RM
    AGUET, M
    [J]. SCIENCE, 1994, 264 (5167) : 1918 - 1921
  • [25] CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells
    Nakano, H
    Yanagita, M
    Gunn, MD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) : 1171 - 1178
  • [26] Mouse plasmacytoid cells:: Long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8+ dendritic cells only after microbial stimulus
    O'Keeffe, M
    Hochrein, H
    Vremec, D
    Caminschi, I
    Miller, JL
    Anders, EM
    Wu, L
    Lahoud, H
    Henri, S
    Scott, B
    Hertzog, P
    Tatarczuch, L
    Shortman, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (10) : 1307 - 1319
  • [27] TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction
    Oshiumi, H
    Matsumoto, M
    Funami, K
    Akazawa, T
    Seya, T
    [J]. NATURE IMMUNOLOGY, 2003, 4 (02) : 161 - 167
  • [28] Dissecting virus entry via endocytosis
    Sieczkarski, SB
    Whittaker, GR
    [J]. JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 1535 - 1545
  • [29] The nature of the principal type 1 interferon-producing cells in human blood
    Siegal, FP
    Kadowaki, N
    Shodell, M
    Fitzgerald-Bocarsly, PA
    Shah, K
    Ho, S
    Antonenko, S
    Liu, YJ
    [J]. SCIENCE, 1999, 284 (5421) : 1835 - 1837
  • [30] Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO